AP report: FDA scientists opposed the Trump administration's move to ease peptides access
News
Archived
•
October 28, 2026
•
2 views
A plan to give people in the United States easier access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. was opposed by most Food and Drug Administration scientific staff members, who had limited input in drafting the policy, according to six people familiar with its development.
Source: PBS NewsHour | https://www.pbs.org/newshour/feeds/rss/headlines - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!


